Glypican-3 (298-306)

Glypican-3

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-329

Synonyms/Alias:Glypican-3 (298-306)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
EYILSLEEL
Areas of Interest
Antigen-presenting Cells; Cancer Research

Glypican-3 (298-306) is a synthetic peptide corresponding to amino acid residues 298 to 306 of the human glypican-3 protein, a heparan sulfate proteoglycan anchored to the cell membrane. As a defined peptide fragment, it is widely recognized for its relevance in studies of cell signaling, developmental biology, and tumor biology, particularly given glypican-3's role in modulating growth factor signaling pathways. Researchers value this peptide for its sequence specificity, which enables precise interrogation of protein-protein interactions, antigenic determinants, and functional motifs within the glypican-3 molecule. Its use is especially pertinent in the context of fundamental research into cellular communication and the molecular mechanisms underlying tissue differentiation and pathogenesis.

Epitope mapping: Glypican-3 (298-306) serves as a valuable tool in epitope mapping studies to define antibody binding sites within the glypican-3 protein. By providing a discrete, sequence-specific fragment, it enables researchers to characterize the linear epitope recognized by monoclonal or polyclonal antibodies. This application is critical for the development and validation of immunoassays, as well as for the engineering of antibody-based detection reagents that require precise knowledge of antigenic regions. The peptide's defined sequence allows for systematic evaluation of antibody specificity and cross-reactivity, supporting the refinement of immunological reagents used in both basic and translational research.

Immunogenicity research: The peptide is frequently employed in studies investigating the immunogenic potential of glypican-3-derived sequences. Its use facilitates the examination of T-cell responses and antigen processing, as researchers can assess how this specific peptide fragment is presented by major histocompatibility complex (MHC) molecules and recognized by cytotoxic T lymphocytes. Such investigations provide insight into the molecular determinants of immune recognition and are instrumental in understanding the role of glypican-3 in immune surveillance, particularly in the context of tumor immunology and antigen-specific immune responses.

Protein interaction studies: The defined sequence of Glypican-3 (298-306) enables its use in probing protein-protein interactions involving glypican-3 or its binding partners. By serving as a molecular probe, the peptide allows researchers to dissect the contribution of this particular region to ligand binding, receptor engagement, or modulation of signaling cascades. This application is particularly relevant in elucidating the structural and functional domains of glypican-3, supporting studies aimed at mapping interaction interfaces and understanding the mechanistic basis of its biological activity.

Peptide-based assay development: The peptide is also utilized as a standard or control in the development of peptide-based analytical assays, such as enzyme-linked immunosorbent assays (ELISA) or mass spectrometry-based detection platforms. Its well-defined structure and sequence specificity make it suitable for calibrating assay sensitivity, establishing detection thresholds, or validating assay performance. This contributes to the generation of reproducible and quantitative data, which is essential for high-quality biochemical and immunological analyses.

Structural and functional motif analysis: Researchers leverage Glypican-3 (298-306) to investigate the structural motifs and functional elements embedded within the glypican-3 protein. By isolating this segment, it becomes possible to explore its role in conformational dynamics, post-translational modifications, or interactions with extracellular matrix components. Such studies enhance the understanding of how discrete glypican-3 regions contribute to the protein's overall architecture and biological function, informing broader efforts in molecular modeling, drug design, and the elucidation of structure-activity relationships.

Source#
Homo sapiens (human)
Epitope
298-306
Restricting HLA
HLA-A24
References
Komori; Clin Cancer Res 2006

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisPeptide CDMOPeptide Synthesis ServicesCustom Conjugation ServicePeptide Modification ServicescGMP Peptide ServicePeptide Analysis ServicesEpitope Mapping Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers